Raytheon Technologies Investing Cash Flow decreased by 10.7% to -$608.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.3%, from -$678.00M to -$608.00M. Over 3 years (FY 2021 to FY 2024), Investing Cash Flow shows a downward trend with a 4.0% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$343.00M | -$378.00M | -$1.23B | -$518.00M | -$618.00M | -$755.00M | -$938.00M | -$579.00M | -$623.00M | -$859.00M | -$978.00M | $693.00M | -$733.00M | -$715.00M | -$779.00M | -$678.00M | -$509.00M | -$549.00M | -$608.00M |
| QoQ Change | — | -10.2% | -224.1% | +57.7% | -19.3% | -22.2% | -24.2% | +38.3% | -7.6% | -37.9% | -13.9% | +170.9% | -205.8% | +2.5% | -9.0% | +13.0% | +24.9% | -7.9% | -10.7% |
| YoY Change | — | — | — | — | -80.2% | -99.7% | +23.4% | -11.8% | -0.8% | -13.8% | -4.3% | +219.7% | -17.7% | +16.8% | +20.3% | -197.8% | +30.6% | +29.5% | +10.3% |